Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription

Here we identify the hematopoietic proto-oncogene Vav1 as a caspase substrate during apoptosis in lymphoid cells. Cleavage of Vav1 is prevented by the caspase inhibitors zDEVD and zVAD as well as by expression of CrmA. Vav1 is cleaved in vivo at the evolutionary conserved caspase consensus cleavage...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hofmann, Thomas G. (VerfasserIn) , Dröge, Wulf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 07 March 2000
In: Oncogene
Year: 2000, Jahrgang: 19, Heft: 9, Pages: 1153-1163
ISSN:1476-5594
DOI:10.1038/sj.onc.1203406
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.onc.1203406
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1203406
Volltext
Verfasserangaben:Thomas G. Hofmann, Steffen P. Hehner, Wulf Dröge and M. Lienhard Schmitz

MARC

LEADER 00000caa a2200000 c 4500
001 1747235423
003 DE-627
005 20220819094302.0
007 cr uuu---uuuuu
008 210203s2000 xx |||||o 00| ||eng c
024 7 |a 10.1038/sj.onc.1203406  |2 doi 
035 |a (DE-627)1747235423 
035 |a (DE-599)KXP1747235423 
035 |a (OCoLC)1341391573 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hofmann, Thomas G.  |d 1971-  |e VerfasserIn  |0 (DE-588)1161034552  |0 (DE-627)1024442586  |0 (DE-576)506322572  |4 aut 
245 1 0 |a Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription  |c Thomas G. Hofmann, Steffen P. Hehner, Wulf Dröge and M. Lienhard Schmitz 
264 1 |c 07 March 2000 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.02.2021 
520 |a Here we identify the hematopoietic proto-oncogene Vav1 as a caspase substrate during apoptosis in lymphoid cells. Cleavage of Vav1 is prevented by the caspase inhibitors zDEVD and zVAD as well as by expression of CrmA. Vav1 is cleaved in vivo at the evolutionary conserved caspase consensus cleavage site DLYD161C, generating the carboxy-terminal cleavage product Vav1p76 of intermediate stability. In vitro caspase assays reveal cleavage of Vav1 at position 161 either by apoptotic cell lysates or by recombinant caspase-3. Mutation of Asp 161 to Ala leads to the usage of the adjacent alternative cleavage sequence DQID150D. Mutation of both cleavage sites at position 150 and 161 protects Vav1 from caspase-mediated proteolysis in vitro and in vivo. The cleavage product Vav1p76 is capable of activating JNK in T-cells, but fails to induce the phosphorylation of p38/HOG1. Vav1p76 displays a diminished capacity to activate the transcription factors NF-AT, AP-1 and NF-κB, and thus completely fails to activate IL-2 transcription. Since Vav1 is essential for IL-2 production and plays a central role for cytoskeletal reorganization, its proteolytic inactivation during apoptosis affects multiple downstream targets. 
700 1 |a Dröge, Wulf  |d -2011  |e VerfasserIn  |0 (DE-588)1178587789  |0 (DE-627)1049465539  |0 (DE-576)517837528  |4 aut 
773 0 8 |i Enthalten in  |t Oncogene  |d London : Springer Nature, 1997  |g 19(2000), 9, Seite 1153-1163  |h Online-Ressource  |w (DE-627)320469964  |w (DE-600)2008404-3  |w (DE-576)096188715  |x 1476-5594  |7 nnas  |a Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription 
773 1 8 |g volume:19  |g year:2000  |g number:9  |g pages:1153-1163  |g extent:11  |a Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription 
856 4 0 |u https://doi.org/10.1038/sj.onc.1203406  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/1203406  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210203 
993 |a Article 
994 |a 2000 
998 |g 1178587789  |a Dröge, Wulf  |m 1178587789:Dröge, Wulf  |d 50000  |e 50000PD1178587789  |k 0/50000/  |p 3 
999 |a KXP-PPN1747235423  |e 3848374404 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Hofmann, Thomas G.","role":"aut","family":"Hofmann","given":"Thomas G."},{"given":"Wulf","family":"Dröge","role":"aut","roleDisplay":"VerfasserIn","display":"Dröge, Wulf"}],"title":[{"title_sort":"Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription","title":"Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 03.02.2021"],"recId":"1747235423","language":["eng"],"name":{"displayForm":["Thomas G. Hofmann, Steffen P. Hehner, Wulf Dröge and M. Lienhard Schmitz"]},"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"07 March 2000"}],"id":{"eki":["1747235423"],"doi":["10.1038/sj.onc.1203406"]},"physDesc":[{"extent":"11 S."}],"relHost":[{"title":[{"subtitle":"including Oncogene reviews","title":"Oncogene","title_sort":"Oncogene"}],"language":["eng"],"recId":"320469964","disp":"Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcriptionOncogene","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.03.05"],"part":{"year":"2000","pages":"1153-1163","issue":"9","volume":"19","text":"19(2000), 9, Seite 1153-1163","extent":"11"},"pubHistory":["Nachgewiesen 14.1997 -"],"id":{"eki":["320469964"],"zdb":["2008404-3"],"issn":["1476-5594"]},"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke"}],"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a HOFMANNTHOCASPASEDEP0720